Related Experiment Video
Updated: Feb 15, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
Interaction of KRas4B protein with C6-ceramide containing lipid model membranes
Lei Li1, Mridula Dwivedi2, Nelli Erwin1
1Faculty of Chemistry and Chemical Biology, Physical Chemistry I, Technical University of Dortmund, Otto-Hahn-Strasse 4a, 44221 Dortmund, Germany; International Max Planck Research School (IMPRS) in Chemical and Molecular Biology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.
Abstract:
Ras proteins are oncoproteins which play a pivotal role in cellular signaling pathways. All Ras proteins' signaling strongly depends on their correct localization in the cell membrane. Over 30% of cancers are driven by mutant Ras proteins, and KRas4B is the Ras isoform most frequently mutated. C6-ceramide has been shown to inhibit the growth activity of KRas4B mutated cells. However, the mechanism underlying this inhibition remains elusive. Here, we established a heterogeneous model biomembrane containing C6-ceramide. C6-ceramide incorporation does not disrupt the lipid membrane. Addition of KRas4B leads to drastic changes in the lateral membrane organization of the membrane, however. In contrast to the partitioning behavior in other membranes, KRas4B forms small, monodisperse nanoclusters dispersed in a fluid-like environment, in all likelihood induced by some kind of lipid sorting mechanism. Fluorescence cross-correlation data indicate no direct interaction between C6-ceramide and KRas4B, suggesting that KRas4B essentially recruits other lipids. A FRET-based binding assay reveals that the stability of KRas4B proteins inserted into the membrane containing C6-ceramide is reduced. Based on the combined results obtained, we postulate a molecular mechanism for the inhibition of KRas4B mutated cells' activity through C6-ceramide.
Insights
C6-ceramide inhibits KRas4B mutated cancer cells by altering their membrane organization. KRas4B forms nanoclusters, reducing protein stability without direct C6-ceramide interaction, revealing a novel inhibition mechanism.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Ras proteins are crucial oncoproteins in cellular signaling, with mutations driving over 30% of cancers.
- KRas4B is the most frequently mutated Ras isoform, and its signaling depends on cell membrane localization.
- C6-ceramide inhibits KRas4B mutated cell growth, but the underlying mechanism is unknown.
Purpose of the Study:
- To elucidate the molecular mechanism by which C6-ceramide inhibits KRas4B mutated cells.
- To investigate the effect of C6-ceramide on KRas4B localization and behavior within a model biomembrane.
Main Methods:
- Established a heterogeneous model biomembrane incorporating C6-ceramide.
- Utilized fluorescence cross-correlation spectroscopy to study KRas4B-lipid interactions.
- Employed Förster Resonance Energy Transfer (FRET)-based binding assays to assess KRas4B protein stability.
Main Results:
- C6-ceramide incorporation did not disrupt the model lipid membrane.
- KRas4B formed small, monodisperse nanoclusters in a fluid-like environment, suggesting a lipid sorting mechanism.
- No direct interaction was observed between C6-ceramide and KRas4B; KRas4B recruited other lipids.
- The stability of KRas4B proteins in the C6-ceramide-containing membrane was reduced.
Conclusions:
- C6-ceramide inhibits KRas4B mutated cells by altering membrane organization and reducing KRas4B protein stability.
- The mechanism involves KRas4B forming nanoclusters and recruiting other lipids, rather than direct interaction with C6-ceramide.
- This study provides a molecular basis for C6-ceramide's anti-cancer activity against KRas4B mutations.
More Related Videos
08:53Using Scaffold Liposomes to Reconstitute Lipid-proximal Protein-protein Interactions In Vitro
Published on: January 11, 2017
07:33Lipid Vesicle-mediated Affinity Chromatography using Magnetic Activated Cell Sorting LIMACS: a Novel Method to Analyze Protein-lipid Interaction
Published on: April 26, 2011
Related Concept Videos
Introduction to Membrane Proteins
Membrane Lipids
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Membrane Proteins
What are Lipids?
Structure of Lipids
Protein Diffusion in the Membrane